These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26767610)

  • 1. Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement.
    Villa AD; Sammut E; Zarinabad N; Carr-White G; Lee J; Bettencourt N; Razavi R; Nagel E; Chiribiri A
    J Cardiovasc Magn Reson; 2016 Jan; 18():4. PubMed ID: 26767610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.
    Ismail TF; Hsu LY; Greve AM; Gonçalves C; Jabbour A; Gulati A; Hewins B; Mistry N; Wage R; Roughton M; Ferreira PF; Gatehouse P; Firmin D; O'Hanlon R; Pennell DJ; Prasad SK; Arai AE
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):49. PubMed ID: 25160568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.
    Camaioni C; Knott KD; Augusto JB; Seraphim A; Rosmini S; Ricci F; Boubertakh R; Xue H; Hughes R; Captur G; Lopes LR; Brown LAE; Manisty C; Petersen SE; Plein S; Kellman P; Mohiddin SA; Moon JC
    Heart; 2020 Jun; 106(11):824-829. PubMed ID: 31822572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.
    Raphael CE; Mitchell F; Kanaganayagam GS; Liew AC; Di Pietro E; Vieira MS; Kanapeckaite L; Newsome S; Gregson J; Owen R; Hsu LY; Vassiliou V; Cooper R; Mrcp AA; Ismail TF; Wong B; Sun K; Gatehouse P; Firmin D; Cook S; Frenneaux M; Arai A; O'Hanlon R; Pennell DJ; Prasad SK
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):26. PubMed ID: 33685501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.
    Jablonowski R; Fernlund E; Aletras AH; Engblom H; Heiberg E; Liuba P; Arheden H; Carlsson M
    Pediatr Cardiol; 2015 Dec; 36(8):1662-9. PubMed ID: 26066352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy.
    Stirrat J; Joncas SX; Salerno M; Drangova M; White J
    J Cardiovasc Magn Reson; 2015 Aug; 17(1):66. PubMed ID: 26248535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
    JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAD detection in patients with intermediate-high pre-test probability: low-dose CT delayed enhancement detects ischemic myocardial scar with moderate accuracy but does not improve performance of a stress-rest CT perfusion protocol.
    Bettencourt N; Ferreira ND; Leite D; Carvalho M; Ferreira WDS; Schuster A; Chiribiri A; Leite-Moreira A; Silva-Cardoso J; Nagel E; Gama V
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1062-1071. PubMed ID: 24011773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-tesla magnetic resonance imaging.
    Tyan CC; Armstrong S; Scholl D; Stirrat J; Blackwood K; El-Sherif O; Thompson T; Wisenberg G; Prato FS; So A; Lee TY; Drangova M; White JA
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):229-38. PubMed ID: 23413422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy.
    Kim EK; Lee SC; Chang SA; Jang SY; Kim SM; Park SJ; Choi JO; Park SW; Jeon ES; Choe YH
    J Cardiovasc Magn Reson; 2020 May; 22(1):30. PubMed ID: 32366254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy.
    Zhi Y; Gui FD; Xue M; Long YT; Miao W; Yi Y; Gao LC; Bing F; Pan SY
    BMC Cardiovasc Disord; 2024 Apr; 24(1):203. PubMed ID: 38594610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
    Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
    Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.
    Flett AS; Hasleton J; Cook C; Hausenloy D; Quarta G; Ariti C; Muthurangu V; Moon JC
    JACC Cardiovasc Imaging; 2011 Feb; 4(2):150-6. PubMed ID: 21329899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Myocardial transit-time" (MyoTT): a novel and easy-to-perform CMR parameter to assess microvascular disease.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2020 Apr; 109(4):488-497. PubMed ID: 31321491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging.
    Kim J; Kochav JD; Gurevich S; Afroz A; Petashnick M; Volo S; Diaz B; Okin PM; Horn E; Devereux RB; Weinsaft JW
    Int J Cardiovasc Imaging; 2014 Dec; 30(8):1559-67. PubMed ID: 25008088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Transl Res; 2009 Dec; 2(4):415-25. PubMed ID: 20560000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy.
    Malahfji M; Senapati A; Debs D; Angulo C; Zhan Y; Nagueh SF; Shah DJ
    Sci Rep; 2020 Sep; 10(1):15977. PubMed ID: 32994462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.